BP
MR

Banyan Partners’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Banyan Partners’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$358K Sell
11,856
-1,807
-13% -$56K 0.03% 342
2014
Q2 		$430K Buy
13,663
+412
+3% +$13.1K 0.04% 325
2014
Q1 		$429K Sell
13,251
-41,126
-76% -$1.44M 0.04% 314
2013
Q4 		$1.98M Buy
54,377
+38,817
+249% +$1.51M 0.14% 161
2013
Q3 		$605K Buy
+15,560
New +$627K 0.05% 208

Other funds holding MR

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.69B AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
GAM
Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Banyan Partners's MR Position: Q3 2014 in Review

Banyan Partners reduced its MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) stake by 13% in Q3 2014, selling an estimated $56K and leaving 11,856 shares worth $358K. The position accounts for 0.03% of the portfolio, ranked #342.

Banyan Partners first reported a position in MR in Q3 2013 and has held it in 5 quarters since. The position peaked at $1.98M in Q4 2013. 129 funds tracked by Wall St. Rank hold MR as of Q3 2014.

  • Banyan Partners held 11,856 shares of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A worth $358K as of Q3 2014.
  • Banyan Partners sold 1,807 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q3 2014, an estimated $56K.
  • MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A made up 0.03% of Banyan Partners's portfolio in Q3 2014, its #342 holding.
  • Banyan Partners first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q3 2013 and has held it in 5 quarters since.
  • Banyan Partners's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $1.98M in Q4 2013.
  • 129 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q3 2014.

Based on Banyan Partners's 13F filing for Q3 2014, filed 14 Nov 2014.